THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Adult

This is a "connection" page, showing publications James George has written about Adult.
Connection Strength

3.042
  1. Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura. Blood Adv. 2022 02 08; 6(3):750-759.
    View in: PubMed
    Score: 0.085
  2. Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia. Blood Adv. 2019 12 10; 3(23):3973-3976.
    View in: PubMed
    Score: 0.073
  3. Treatment of Immune Thrombocytopenia in Adults: Version 2019. Mayo Clin Proc. 2019 11; 94(11):2161-2163.
    View in: PubMed
    Score: 0.072
  4. Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future. Am J Hematol. 2019 09; 94(9):E242-E244.
    View in: PubMed
    Score: 0.071
  5. Embolic stroke of undetermined source in a young woman. Am J Hematol. 2019 09; 94(9):1044-1048.
    View in: PubMed
    Score: 0.071
  6. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43.
    View in: PubMed
    Score: 0.066
  7. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
    View in: PubMed
    Score: 0.062
  8. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov; 92(11):1224-1232.
    View in: PubMed
    Score: 0.062
  9. A postpartum perfect storm. Am J Hematol. 2017 Oct; 92(10):1105-1110.
    View in: PubMed
    Score: 0.062
  10. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
    View in: PubMed
    Score: 0.062
  11. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.062
  12. After the Party's Over. N Engl J Med. 2017 Jan 05; 376(1):74-80.
    View in: PubMed
    Score: 0.060
  13. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
    View in: PubMed
    Score: 0.058
  14. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
    View in: PubMed
    Score: 0.057
  15. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
    View in: PubMed
    Score: 0.053
  16. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
    View in: PubMed
    Score: 0.052
  17. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
    View in: PubMed
    Score: 0.051
  18. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
    View in: PubMed
    Score: 0.049
  19. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80.
    View in: PubMed
    Score: 0.048
  20. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
    View in: PubMed
    Score: 0.047
  21. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
    View in: PubMed
    Score: 0.046
  22. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
    View in: PubMed
    Score: 0.046
  23. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012; 27(6):302-11.
    View in: PubMed
    Score: 0.044
  24. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
    View in: PubMed
    Score: 0.043
  25. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
    View in: PubMed
    Score: 0.043
  26. Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
    View in: PubMed
    Score: 0.043
  27. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9.
    View in: PubMed
    Score: 0.042
  28. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
    View in: PubMed
    Score: 0.041
  29. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
    View in: PubMed
    Score: 0.037
  30. Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol. 2010 Jan; 85(1):71-4.
    View in: PubMed
    Score: 0.037
  31. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37.
    View in: PubMed
    Score: 0.035
  32. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101.
    View in: PubMed
    Score: 0.034
  33. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009; 153-8.
    View in: PubMed
    Score: 0.034
  34. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol. 2009 Mar; 144(5):742-54.
    View in: PubMed
    Score: 0.034
  35. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15.
    View in: PubMed
    Score: 0.034
  36. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
    View in: PubMed
    Score: 0.034
  37. Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75.
    View in: PubMed
    Score: 0.033
  38. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
    View in: PubMed
    Score: 0.033
  39. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
    View in: PubMed
    Score: 0.032
  40. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
    View in: PubMed
    Score: 0.032
  41. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43.
    View in: PubMed
    Score: 0.031
  42. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
    View in: PubMed
    Score: 0.031
  43. Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report. Am J Hematol. 2007 Jun; 82(6):496-7.
    View in: PubMed
    Score: 0.031
  44. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
    View in: PubMed
    Score: 0.030
  45. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006 May 04; 354(18):1927-35.
    View in: PubMed
    Score: 0.028
  46. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 May; 12(5):506-10.
    View in: PubMed
    Score: 0.028
  47. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6.
    View in: PubMed
    Score: 0.028
  48. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol. 2005 Aug; 3(8):627-32.
    View in: PubMed
    Score: 0.027
  49. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6.
    View in: PubMed
    Score: 0.027
  50. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep. 2005 May; 4(3):167-9.
    View in: PubMed
    Score: 0.026
  51. Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy. Blood Adv. 2024 Jul 23; 8(14):3718-3720.
    View in: PubMed
    Score: 0.025
  52. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
    View in: PubMed
    Score: 0.025
  53. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
    View in: PubMed
    Score: 0.024
  54. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.024
  55. Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. Hematol J. 2004; 5 Suppl 3:S12-4.
    View in: PubMed
    Score: 0.024
  56. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
    View in: PubMed
    Score: 0.024
  57. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep. 2003 Sep; 2(5):381-7.
    View in: PubMed
    Score: 0.024
  58. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
    View in: PubMed
    Score: 0.024
  59. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.023
  60. Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002 Mar; 16(1):37-8.
    View in: PubMed
    Score: 0.021
  61. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021 06 24; 137(25):3563-3575.
    View in: PubMed
    Score: 0.020
  62. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021 04 08; 137(14):1855-1861.
    View in: PubMed
    Score: 0.020
  63. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001 Mar; 27(6):641-6.
    View in: PubMed
    Score: 0.020
  64. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 2001; 16(4):202-9.
    View in: PubMed
    Score: 0.020
  65. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood. 2000 Aug 15; 96(4):1223-9.
    View in: PubMed
    Score: 0.019
  66. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
    View in: PubMed
    Score: 0.019
  67. Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7.
    View in: PubMed
    Score: 0.018
  68. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
    View in: PubMed
    Score: 0.017
  69. Idiopathic thrombocytopenic purpura: diagnosis and management. Am J Med Sci. 1998 Aug; 316(2):87-93.
    View in: PubMed
    Score: 0.017
  70. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
    View in: PubMed
    Score: 0.017
  71. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med. 1998 Feb; 30(1):38-44.
    View in: PubMed
    Score: 0.016
  72. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol. 1998 Jan; 35(1 Suppl 1):5-8.
    View in: PubMed
    Score: 0.016
  73. Clinical decisions in idiopathic thrombocytopenic purpura. Hosp Pract (1995). 1997 Sep 15; 32(9):159-60, 163-6, 169-70, passim.
    View in: PubMed
    Score: 0.016
  74. Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura. Curr Opin Hematol. 1996 Sep; 3(5):335-40.
    View in: PubMed
    Score: 0.015
  75. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40.
    View in: PubMed
    Score: 0.014
  76. The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med. 2015 Aug; 90(8):1061-6.
    View in: PubMed
    Score: 0.013
  77. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
    View in: PubMed
    Score: 0.013
  78. Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 2015 Mar; 55(3):657-60.
    View in: PubMed
    Score: 0.013
  79. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.012
  80. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
    View in: PubMed
    Score: 0.012
  81. A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2013 Feb; 90(2):121-6.
    View in: PubMed
    Score: 0.011
  82. Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21.
    View in: PubMed
    Score: 0.011
  83. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.011
  84. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303.
    View in: PubMed
    Score: 0.010
  85. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
    View in: PubMed
    Score: 0.010
  86. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
    View in: PubMed
    Score: 0.010
  87. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13.
    View in: PubMed
    Score: 0.009
  88. Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol. 2010 May; 149(4):623-5.
    View in: PubMed
    Score: 0.009
  89. Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol. 2009 Dec 01; 83(6):559-64.
    View in: PubMed
    Score: 0.009
  90. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.009
  91. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.009
  92. Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5.
    View in: PubMed
    Score: 0.008
  93. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008 Feb 08; 6:13.
    View in: PubMed
    Score: 0.008
  94. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403.
    View in: PubMed
    Score: 0.008
  95. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb; 83(2):150-4.
    View in: PubMed
    Score: 0.008
  96. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008 Jan 15; 85(1):22-8.
    View in: PubMed
    Score: 0.008
  97. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol. 2007 Nov; 139(3):486-93.
    View in: PubMed
    Score: 0.008
  98. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May; 29(5):950-962.
    View in: PubMed
    Score: 0.008
  99. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22; 5:11.
    View in: PubMed
    Score: 0.008
  100. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2007 Jan; 136(1):146-9.
    View in: PubMed
    Score: 0.007
  101. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
    View in: PubMed
    Score: 0.007
  102. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
    View in: PubMed
    Score: 0.006
  103. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
    View in: PubMed
    Score: 0.006
  104. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20.
    View in: PubMed
    Score: 0.006
  105. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
    View in: PubMed
    Score: 0.005
  106. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES